Check the

K4 MEDICAL LIMITED

Company
K4 MEDICAL LIMITED (09123622)

K4 MEDICAL

Phone: +44 (0)7595 690 010
A⁺ rating

KEY FINANCES

Year
2016
Assets
£9.42k ▼ £-1.6k (-14.55 %)
Cash
£0k ▼ £0k (NaN)
Liabilities
£7.24k ▲ £1.22k (20.25 %)
Net Worth
£2.18k ▼ £-2.82k (-56.39 %)

REGISTRATION INFO

Company name
K4 MEDICAL LIMITED
Company number
09123622
Status
Active
Categroy
Private Limited Company
Date of Incorporation
09 Jul 2014
Age - 10 years
Home Country
United Kingdom

CONTACTS

Website
k4medical.co.uk
Phones
+44 (0)7595 690 010
07595 690 010
Registered Address
C/O RUSSELL & CO 1ST FLOOR, THE SMITHYSIDE,
7 BELL VILLAS,
PONTELAND,
NEWCASTLE UPON TYNE,
UNITED KINGDOM,
NE20 9BD

ECONOMIC ACTIVITIES

46180
Agents specialized in the sale of other particular products

LAST EVENTS

18 Jul 2016
Confirmation statement made on 9 July 2016 with updates
02 Feb 2016
Registered office address changed from 4 Ladyrigg Ponteland Northumberland NE209QS to C/O Russell & Co 1st Floor, the Smithyside 7 Bell Villas Ponteland Newcastle upon Tyne NE20 9BD on 2 February 2016
01 Feb 2016
Director's details changed for Emma Fynan-Stovold on 1 February 2016

See Also


Last update 2018

K4 MEDICAL LIMITED DIRECTORS

Emma Fynan Stovold

  Acting PSC
Appointed
09 July 2014
Occupation
Sales Executive
Role
Director
Age
49
Nationality
British
Address
C/O Russell & Co, 1st Floor, The Smithyside, 7 Bell Villas, Ponteland, Newcastle Upon Tyne, United Kingdom, NE20 9BD
Country Of Residence
United Kingdom
Name
FYNAN-STOVOLD, Emma
Notified On
6 April 2016
Nature Of Control
Ownership of shares – More than 25% but not more than 50%

Kristin Stovold

  Acting PSC
Appointed
09 July 2014
Occupation
Sales Executive
Role
Director
Age
44
Nationality
British
Address
C/O Russell & Co, 1st Floor, The Smithyside, 7 Bell Villas, Ponteland, Newcastle Upon Tyne, United Kingdom, NE20 9BD
Country Of Residence
England
Name
STOVOLD, Kristin
Notified On
6 April 2016
Nature Of Control
Ownership of shares – More than 50% but less than 75%

REVIEWS


Check The Company
Excellent according to the company’s financial health.